Germany-based Stada Arzneimittel AG has announced a strategic distribution and promotion partnership with China’s state-owned pharmaceutical company, CR Sanjiu (SHE: 000999). This collaboration aims to enhance the reach of Stada’s cough and cold brands across hospital, pharmacy, and e-commerce channels in China.
Key Brands Included in the Partnership
The brands involved in this agreement include Shidagong, Gelite, Ruike, and Xikening, all of which are already manufactured at Stada’s facility in Beijing. This partnership not only strengthens Stada’s presence in the Chinese market but also opens avenues for the distribution of additional over-the-counter products across various therapeutic areas.
Expanding Market Opportunities
The deal with CR Sanjiu positions Stada to leverage the extensive distribution network of a state-owned enterprise, facilitating greater access to Chinese consumers. The partnership also leaves room for future collaboration on Stada’s other products, potentially broadening their portfolio in the competitive Chinese pharmaceutical landscape.- Flcube.com
